CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,213,800 | +12.5% | 253,933 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $1,079,215 | -29.2% | 253,933 | -11.5% | 0.00% | -33.3% |
| Q1 2023 | $1,524,145 | -15.4% | 287,033 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $1,802,567 | -50.8% | 287,033 | -17.3% | 0.00% | -55.6% |
| Q3 2022 | $3,661,000 | +81.2% | 347,033 | -6.7% | 0.01% | +80.0% |
| Q2 2022 | $2,020,000 | -63.9% | 372,033 | -38.9% | 0.01% | -54.5% |
| Q1 2022 | $5,591,000 | -39.2% | 609,067 | 0.0% | 0.01% | -35.3% |
| Q4 2021 | $9,191,000 | -36.8% | 609,067 | 0.0% | 0.02% | -41.4% |
| Q3 2021 | $14,538,000 | – | 609,067 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
| Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
| PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
| CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
| Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
| Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
| Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
| Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |